205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-10.04%
Revenue decline while MCHP shows 2.93% growth. Joel Greenblatt would examine competitive position erosion.
-4.14%
Cost reduction while MCHP shows 2.15% growth. Joel Greenblatt would examine competitive advantage.
-13.64%
Gross profit decline while MCHP shows 3.30% growth. Joel Greenblatt would examine competitive position.
-4.00%
Margin decline while MCHP shows 0.36% expansion. Joel Greenblatt would examine competitive position.
-2.34%
R&D reduction while MCHP shows 5.63% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.71%
Operating expenses reduction while MCHP shows 2.53% growth. Joel Greenblatt would examine advantage.
-3.64%
Total costs reduction while MCHP shows 2.33% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
5.31%
D&A growth while MCHP reduces D&A. John Neff would investigate differences.
-15.26%
EBITDA decline while MCHP shows 3.24% growth. Joel Greenblatt would examine position.
-5.80%
EBITDA margin decline while MCHP shows 0.30% growth. Joel Greenblatt would examine position.
-18.97%
Operating income decline while MCHP shows 4.48% growth. Joel Greenblatt would examine position.
-9.93%
Operating margin decline while MCHP shows 1.51% growth. Joel Greenblatt would examine position.
-50.00%
Other expenses reduction while MCHP shows 6.48% growth. Joel Greenblatt would examine advantage.
-19.46%
Pre-tax income decline while MCHP shows 5.20% growth. Joel Greenblatt would examine position.
-10.47%
Pre-tax margin decline while MCHP shows 2.20% growth. Joel Greenblatt would examine position.
-16.90%
Tax expense reduction while MCHP shows 8.74% growth. Joel Greenblatt would examine advantage.
-19.78%
Net income decline while MCHP shows 4.08% growth. Joel Greenblatt would examine position.
-10.82%
Net margin decline while MCHP shows 1.12% growth. Joel Greenblatt would examine position.
-20.21%
EPS decline while MCHP shows 3.77% growth. Joel Greenblatt would examine position.
-19.46%
Diluted EPS decline while MCHP shows 4.81% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Both companies reducing diluted shares. Martin Whitman would check patterns.